Regulatory Considerations for Fluid & Imaging Biomarkers of Neurodegeneration & Neuroinflammation
Time: 8:45 am
day: Conference Day One
Details:
- Outline the different types of biomarkers using the BEST classification and their application in clinical trials
- Considerations for analytic and clinical validation of biomarkers
- Considerations for use of biomarkers as surrogate endpoints
